AJP - Endo AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 295: E1447-E1454, 2008. First published September 23, 2008; doi:10.1152/ajpendo.90362.2008
0193-1849/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/6/E1447    most recent
90362.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lefort, N.
Right arrow Articles by Marette, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lefort, N.
Right arrow Articles by Marette, A.

The {alpha}-subunit of AMPK is essential for submaximal contraction-mediated glucose transport in skeletal muscle in vitro

Natalie Lefort,1,3,* Emmanuelle St.-Amand,1,3,* Sébastien Morasse,1,3 Claude H. Côté,2,3 and André Marette1,3

Departments of 1Anatomy and Physiology and 2Rehabilitation, and 3Lipid Research Unit, Laval University Hospital Research Center, Québec, Canada

Submitted 14 April 2008 ; accepted in final form 22 September 2008

AMP-activated protein kinase (AMPK) is a key signaling protein in the regulation of skeletal muscle glucose uptake, but its role in mediating contraction-induced glucose transport is still debated. The effect of contraction on glucose transport is impaired in EDL muscle of transgenic mice expressing a kinase-dead, dominant negative form of the AMPK{alpha}2 subunit (KD-AMPK{alpha}2 mice). However, maximal force production is reduced in this muscle, raising the possibility that the defect in glucose transport was due to a secondary decrease in force production and not impaired AMPK{alpha}2 activity. Generation of force-frequency curves revealed that muscle force production is matched between wild-type (WT) and KD-AMPK{alpha}2 mice at frequencies ≤50 Hz. Moreover, AMPK activation is already maximal at 50 Hz in muscles of WT mice. When EDL muscles from WT mice were stimulated at a frequency of 50 Hz for 2 min (200-ms train, 1/s, 30 volts), contraction caused an ~3.5-fold activation of AMPK{alpha}2 activity and an ~2-fold stimulation of glucose uptake. Conversely, whereas force production was similar in EDL of KD-AMPK{alpha}2 animals, no effect of contraction was observed on AMPK{alpha}2 activity, and glucose uptake stimulation was reduced by 50% (P < 0.01) As expected, 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranosyl 5'-monophosphate (AICAR) caused a 2.3-fold stimulation of AMPK{alpha}2 activity and a 1.7-fold increase in glucose uptake in EDL from WT mice, whereas no effect was detected in muscle from KD-AMPK{alpha}2 mice. These data demonstrate that AMPK activation is essential for both AICAR and submaximal contraction-induced glucose transport in skeletal muscle but that AMPK-independent mechanisms are also involved.

adenosine 5'-monophosphate-activated protein kinase



Address for reprint requests and other correspondence: A. Marette, Dept. of Physiology & Lipid Research Unit, Laval Univ. Hospital Research Center, 2705, Laurier Bld., Ste-Foy, (Québec), Canada, G1V 4G2 (e-mail: andre.marette{at}crchul.ulaval.ca)




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. J. Maarbjerg, S. B. Jorgensen, A. J. Rose, J. Jeppesen, T. E. Jensen, J. T. Treebak, J. B. Birk, P. Schjerling, J. F. P. Wojtaszewski, and E. A. Richter
Genetic impairment of AMPK{alpha}2 signaling does not reduce muscle glucose uptake during treadmill exercise in mice
Am J Physiol Endocrinol Metab, October 1, 2009; 297(4): E924 - E934.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. S. Lee-Young, S. R. Griffee, S. E. Lynes, D. P. Bracy, J. E. Ayala, O. P. McGuinness, and D. H. Wasserman
Skeletal Muscle AMP-activated Protein Kinase Is Essential for the Metabolic Response to Exercise in Vivo
J. Biol. Chem., September 4, 2009; 284(36): 23925 - 23934.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Pehmoller, J. T. Treebak, J. B. Birk, S. Chen, C. MacKintosh, D. G. Hardie, E. A. Richter, and J. F. P. Wojtaszewski
Genetic disruption of AMPK signaling abolishes both contraction- and insulin-stimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscle
Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E665 - E675.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. L. Williamson, D. C. Butler, and S. E. Alway
AMPK inhibits myoblast differentiation through a PGC-1{alpha}-dependent mechanism
Am J Physiol Endocrinol Metab, August 1, 2009; 297(2): E304 - E314.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. J. Rose, T. J. Alsted, T. E. Jensen, J. B. Kobbero, S. J. Maarbjerg, J. Jensen, and E. A. Richter
A Ca2+-calmodulin-eEF2K-eEF2 signalling cascade, but not AMPK, contributes to the suppression of skeletal muscle protein synthesis during contractions
J. Physiol., April 1, 2009; 587(7): 1547 - 1563.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.